CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $39,251
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$39,251. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-20 | Equels Thomas K CEO & President | Purchase | +60,110 | $0.18 | $11K | 1,552,968 |
| 2024-09-16 | Equels Thomas K CEO & President | Purchase | +5,000 | $0.30 | $2K | 1,493,042 |
| 2024-09-13 | Equels Thomas K CEO & President | Purchase | +20,000 | $0.31 | $6K | 1,488,042 |
| 2024-09-11 | Equels Thomas K CEO & President | Grant or award | +312,500 | $0.32 | $100K | 1,468,042 |
| 2024-08-12 | Rodino Peter W III COO, Secretary, Gen. Counsel | Grant or award | +188,679 | $0.27 | $50K | 401,262 |
| 2024-08-12 | Equels Thomas K CEO & President | Grant or award | +377,358 | $0.27 | $100K | 1,155,542 |
| 2024-05-06 | Equels Thomas K CEO & President | Purchase | +61,729 | $0.41 | $25K | 778,184 |
| 2024-05-06 | Rodino Peter W III COO, Secretary, Gen. Counsel | Purchase | +30,865 | $0.41 | $13K | 212,583 |
| 2024-03-21 | BRYAN NANCY Director | Purchase | +38,462 | $0.39 | $15K | 38,462 |
| 2024-03-15 | Rodino Peter W III COO, Secretary, Gen. Counsel | Purchase | +37,879 | $0.33 | $13K | 181,718 |
| 2024-03-15 | Equels Thomas K CEO & President | Purchase | +75,758 | $0.33 | $25K | 716,455 |
| 2024-03-15 | APPELROUTH STEWART Director | Purchase | +90,910 | $0.33 | $30K | 239,765 |
| 2023-11-30 | Rodino Peter W III COO, Secretary, Gen. Counsel | Grant or award · Options | +100,000 | 100,000 | ||
| 2023-11-30 | Equels Thomas K CEO & President | Grant or award · Options | +300,000 | 300,000 | ||
| 2023-11-27 | Equels Thomas K CEO & President | Purchase | +33,861 | $0.44 | $15K | 640,697 |
| 2023-09-29 | Equels Thomas K CEO & President | Purchase | +22,676 | $0.44 | $10K | 606,836 |
| 2023-08-25 | Equels Thomas K CEO & President | Purchase | +8,222 | $0.67 | $6K | 584,160 |
| 2023-08-24 | Equels Thomas K CEO & President | Purchase | +14,993 | $0.67 | $10K | 575,938 |
| 2023-07-17 | Equels Thomas K CEO & President | Purchase | +16,950 | $0.59 | $10K | 560,945 |
| 2023-03-10 | APPELROUTH STEWART Director | Other disposition | −68,208 | $1.23 | $84K | 148,855 |
Page 4 of 14 · 263 trades